The American Journal of Managed Care

Streamlining Lymphoma Care With Multi-Indication Bispecifics

While multi-indication bispecific therapies are likely to expand in lymphoma, their use must remain driven by efficacy, with ...
MM&M

Novartis receives supplemental indication for pro-motility agent Zelnorm

Novartis reported that the FDA has approved a supplemental indication for its pro-motility agent Zelnorm for the treatment of chronic idiopathic constipation in male and female patients less than 65 ...
Monthly Prescribing Reference

Gadavist Contrast Agent Gains Expanded Indication

Gadavist Contrast Agent Gains Expanded Indication Bayer HealthCare announced that he FDA has approved a new indication for Gadavist (gadobutrol) injection for IV use with MRI of the breast to assess ...
Seeking Alpha

GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent

The latest approval will help provide clearer echocardiogram images for cardiologists to diagnose heart conditions in pediatric patients Optison is the only polyethylene glycol (PEG)-free ultrasound ...
Seeking Alpha

FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients

The FDA has approved an updated label for Vizamyl (flutemetamol F 18 injection), including quantification which enables a more continuous and objective measure of amyloid in the brain This approval ...